Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal modelsHan-Yi Huang, Chi‐Huey Wong, Yo-Min Liu et al.|Science Translational Medicine|2022Cited by 127
A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cellsYi‐An Ko, Kuo‐I Lin, Yueh‐Hsiang Yu et al.|PLoS Pathogens|2021Cited by 37
Impact of glycosylation on a broad-spectrum vaccine against SARS-CoV-2Han-Yi Huang, Chi‐Huey Wong, Hsin-Yu Liao et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 3